May 13, 2013
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business

May 8, 2013
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.

Products in Development

Human Health

Bioniche has developed a technology for the treatment of human cancers. The first product developed from this technology is Urocidin™, a formulation of Mycobacterial Cell Wall-DNA Complex (MCC) for the treatment of bladder cancer. A Phase III clinical program is underway, with one Phase III clinical trial completed.

For more information about the Company’s clinical programs, please contact Bioniche Therapeutics at clinicaltrials@bioniche.com

Marketed Products

Animal Health Products

Information about Bioniche Animal Health products can be found at www.bionicheanimalhealth.com

One Health Products

Econiche™ is the first marketed product of the Bioniche One Health division.

Contact Bioniche One Health